CSE:NEVI - Post Discussion
Post by
Traderstock101 on Dec 15, 2021 8:46am
======> Pascal cancels $900,000 private placement <=======
2021-12-15 02:14 ET - News Release
Mr. Patrick Gray reports
PASCAL BIOSCIENCES CANCELS PRIVATE PLACEMENT FINANCING
Pascal Biosciences Inc. has cancelled its most recent private placement. On Oct. 28, 2021, the company announced a non-brokered private placement financing of up to $900,000. Pascal has determined in light of market conditions that the current offering should be cancelled until further notice. Pascal is now looking at less dilutive financing options going forward.
About Pascal Biosciences Inc.
Pascal is a biotechnology company advancing innovative therapies for serious diseases. In addition to a targeted therapy for acute lymphoblastic leukemia, Pascal is developing cannabinoid-based treatments for cancer. These compounds include PAS-403, which is advancing into clinical trials for the treatment of glioblastoma, and PAS-393, an immunostimulatory cannabinoid to be used in combination with checkpoint inhibitor therapy to treat multiple cancers. The PAS-393 program is being developed collaboratively with SoRSE technology.
Be the first to comment on this post